Pfizer (PFE) confirms that it received a letter from the US House committee that it is probing China drug trials
#PFIZER INC#PFE.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#PFE#US EQUITIES#CHINA